Premium
The strange case of the lost NRAS mutation in a child with juvenile myelomonocytic leukemia
Author(s) -
De Filippi Paola,
Zecca Marco,
Novara Francesca,
Lisini Daniela,
Maserati Emanuela,
Pasquali Francesco,
Rosti Vittorio,
CarloStella Carmelo,
Zavras Niki,
Cagioni Claudia,
Zuffardi Orsetta,
Pagliara Daria,
Danesino Cesare,
Locatelli Franco
Publication year - 2012
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.23401
Subject(s) - juvenile myelomonocytic leukemia , medicine , neuroblastoma ras viral oncogene homolog , juvenile , mutation , leukemia , pediatrics , cancer research , genetics , immunology , cancer , biology , haematopoiesis , gene , stem cell , kras , colorectal cancer
Juvenile myelomonocytic leukemia (JMML) is a rare myelodysplastic/myeloproliferative disorder of early childhood characterized by mutations of the RAS‐RAF‐MAP kinase signaling pathway. We report the case of a child with a diagnosis of JMML carrying two mutations of NRAS gene (c.37G>C and c.38G>A) independently occurring in long‐term culture initiating cells. However, only the former was consistently found in more mature hematopoietic cells, suggesting that cancer transformation may lead to the loss of a mutation. This case also indicates that molecular analysis on cell types other than peripheral blood leukocytes may be useful to obtain relevant biological information on JMML pathogenesis. Pediatr Blood Cancer 2012;59:580–582. © 2011 Wiley Periodicals, Inc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom